References
- Apostolopoulos V , BojarskaJ , ChaiT-Tet al. A global review on short peptides: frontiers and perspectives. Molecules26(2), 430 (2021).
- Wang L , WangN , ZhangWet al. Therapeutic peptides: current applications and future directions. Signal Transduct. Target. Ther.7(1), 48 (2022).
- Diao L , MeibohmB. Pharmacokinetics and pharmacokinetic–pharmacodynamic correlations of therapeutic peptides. Clin. Pharmacokinet.52(10), 855–868 (2013).
- Bajracharya R , SongJG , BackSY , HanH-K. Recent advancements in non-invasive formulations for protein drug delivery. Comput. Struct. Biotechnol. J.17, 1290–1308 (2019).
- Muheem A , ShakeelF , JahangirMAet al. A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives. Saudi Pharm. J.24(4), 413–428 (2016).
- Torchilin V . Intracellular delivery of protein and peptide therapeutics. Drug Discov. Today Technol.5(2–3), e95–e103 (2008).
- Depreter F , PilcerG , AmighiK. Inhaled proteins: challenges and perspectives. Int. J. Pharm.447(1–2), 251–280 (2013).
- Reinholz J , LandfesterK , MailänderV. The challenges of oral drug delivery via nanocarriers. Drug Deliv.25(1), 1694–1705 (2018).
- Chavda VP , NallaLV , BalarPet al. Advanced phytochemical-based nanocarrier systems for the treatment of breast cancer. Cancers15(4), 1023 (2023).
- Zhu Q , ChenZ , PaulPK , LuY , WuW , QiJ. Oral delivery of proteins and peptides: challenges, status quo and future perspectives. Acta Pharm. Sin. B.11(8), 2416–2448 (2021).
- Chavda VP , BalarPC , PatelSB. Nanotheranostics-based management of head and neck cancer. Nanotheranostics7(2), 202–209 (2023).
- Jash A , UbeyitogullariA , RizviSSH. Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances. J. Mater. Chem. B.9(24), 4773–4792 (2021).
- Sharma A . Liposomes in drug delivery: progress and limitations. Int. J. Pharm.154(2), 123–140 (1997).
- Chavda VP , ViholD , MehtaBet al. Phytochemical-loaded liposomes for anticancer therapy: an updated review. Nanomed.17(8), 547–568 (2022).
- Makhlof A , FujimotoS , TozukaY , TakeuchiH. In vitro and in vivo evaluation of WGA–carbopol modified liposomes as carriers for oral peptide delivery. Eur. J. Pharm. Biopharm.77(2), 216–224 (2011).
- Kafka AP , McLeodBJ , RadesT , McDowellA. Release and bioactivity of PACA nanoparticles containing D-Lys6-GnRH for brushtail possum fertility control. J. Control. Rel.149(3), 307–313 (2011).
- Ayesa U , ChongPL-G. Polar lipid fraction E from Sulfolobus acidocaldarius and Dipalmitoylphosphatidylcholine can form stable yet thermo-sensitive tetraether/diester hybrid archaeosomes with controlled release capability. Int. J. Mol. Sci.21(21), 8388 (2020).
- Li Z , ZhangL , SunW , DingQ , HouY , XuY. Archaeosomes with encapsulated antigens for oral vaccine delivery. Vaccine29(32), 5260–5266 (2011).
- Li Z , ChenJ , SunW , XuY. Investigation of archaeosomes as carriers for oral delivery of peptides. Biochem. Biophys. Res. Commun.394(2), 412–417 (2010).
- Zhang Y , WeiW , LvP , WangL , MaG. Preparation and evaluation of alginate–chitosan microspheres for oral delivery of insulin. Eur. J. Pharm. Biopharm.77(1), 11–19 (2011).
- Cao S , XuS , WangHet al. Nanoparticles: oral delivery for protein and peptide drugs. AAPS PharmSciTech.20(5), 190 (2019).
- Sung YK , KimSW. Recent advances in polymeric drug delivery systems. Biomater. Res.24(1), 12 (2020).